Daily Pill for Pancreatic Cancer
Science & Medicine
Thursday, August 27, 2026 - 7 minutes
The FDA recently approved Rasonque (daraxonrasib), a first-in-class daily oral pill developed by Revolution Medicines for adults with advanced or metastatic pancreatic cancer.